SSSana Sarfaraz

Sana Sarfaraz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sana Sarfaraz has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Phytochemical-Enriched Walnut Energy Bar Attenuates Chlorpromazine-Induced Neurotoxicity via Modulation of Oxidative Stress and TNF-α-Mediated Inflammation

    by Hira Raees, Sana Sarfaraz, Fatima Qamar, Mehwish Murad Ali, Maria Rahat, Asma Eraj, Sidra Zubair

    Objective:This study aimed to investigate the neuroprotective activity of a walnut-based energy bar in drug-induced Parkinsonism in rats.Methodology:Wistar rats (n = 24) were divided into four groups: control (standard diet), disease (standard diet + chlorpromazine 3 mg/kg, intraperitoneal), standard treatment (standard diet +carbidopa+ levodopa (100 + 25 mg/kg, oral)), and walnut energy bar-treated (standard diet + walnut energy bar 1 g/kg/day for one month). Motor functions were assessed using standard behavioral tests. The antioxidant potential of the energy bar was analyzed using the 2, 2-Diphenyl-1-picrylhydrazyl (DPPH) assay. The walnut energy bar was analyzed by gas chromatography-mass spectrometry (GC-MS), confirming the presence of bioactive compounds, and high-performance liquid chromatography (HPLC) was used to quantify ferulic acid and cinnamic acid. Tumor necrosis factor-alpha (TNF-α), glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), and malondialdehyde (MDA) levels were measured, and histopathological examination was performed on rat brain tissue.Results:Parkinsonism was successfully induced in rats, as evidenced by motor dysfunction, higher TNF-α and MDA levels, and lower GSH, along with a decline in antioxidant defense mechanisms (CAT, SOD). These biochemical alterations were improved in the walnut energy bar-treated group, suggesting neuroprotective and anti-inflammatory effects. Bioactive compounds identified by GC–MS, along with ferulic and cinnamic acids quantified by HPLC, were associated with the neuroprotective potential of the bar. Enzyme-linked immunosorbent assay (ELISA) and oxidative stress markers further supported these findings. These results were further validated by histopathological findings that showed neurodegeneration in the disease group and preserved neuronal architecture in the group treated with the walnut energy bar.Conclusion:The walnut energy bar-treated group exhibited significant neuroprotective, antioxidant, and anti-inflammatory activity. These findings suggest that a functional walnut energy bar may serve as a dietary intervention for managing drug-induced Parkinsonism symptoms.

  • Open Access

    The Therapeutic Potential of Phaseolus vulgaris in Alzheimer’s Disease: Insights From Experimental Rodent Model

    by Rabia Munawwar, Sana Sarfaraz, Rahila Ikram, Humera Anser

    Alzheimer’s disease (AD) is a devastating neurological ailment affecting millions of people worldwide. For this neurological disease, there are numerous pharmacological and supportive treatments available. Several organic products are currently being investigated for AD. In a recent study, a variety of methods were used to conduct research and evaluate this advantageous effect, including passive avoidance tests, histopathology, biogenic amine assessment, and GC‐MS analysis. For this study, three groups were made of albino rats of both genders. Group I was the negative control group (administered standard diet), Group II was treated with 500 mg/kg beans, and Group III was given 1000 mg/kg. All three groups were induced Alzheimer’s by giving 2.5 mg/kg diazepam prior to the start of the treatment. The results showed that a significantly higher dosage level of 1000 mg/kg was most effective at preventing dementia in AD‐induced rats as compared to the lower dose evaluated. Passive avoidance tests, GC‐MS analysis, which revealed acetylcholine activity and other beneficial compounds like squalene, isoglutamine, and pyrrolizine, as well as histopathological analysis, all supported the effectiveness of this nutritional option. The findings unmistakably demonstrated that 1000 mg/kg red beans are very helpful in reducing dementia in AD‐induced rats.

  • Open Access

    Cumulative Hepatoprotective, Antihyperlipidemic and Antioxidant Effects of Methanolic Seeds Extract of Citrullus lanatus , Cucumis melo , Cucumis sativus , and Cucurbita maxima With GC – MS Profile

    by Hina Ilyas, Sadia Ghousia Baig, Sana Sarfaraz, Farzana Sadaf, Afshan Siddiq, Ali Asgher, Muhammad Osama, Qudsia Basri, Calvin R Wei

    The complex pathophysiological mechanism of nonalcoholic fatty liver (NAFLD) disease has made the prevention and treatment of the disease problematic. The aim of the current study is to evaluate the cumulative hepatoprotective, antihyperlipidemic as well as antioxidant actions of methanolic seed extracts of Citrullus lanatus (CL), Cucumis melo (CM), Cucumis sativus (CS), and Cucurbita maxima (CuM) in NAFLD induced by a high‐fat diet along with 20% fructose water in a rat model. A total of 40 male Wistar rats were kept in five groups. Group I (control) rats received 5% Tween 80; Group II (Negative control) rats were given a high‐fat meal with a 20% fructose solution; Groups III and IV received a combination of methanolic seed extract at a dose of 250 and 500 mg/kg, respectively, + high‐fat diet/20% fructose water, while Group V (Positive control) received Atorvastatin (10 mg/kg) and Metformin (200 mg/kg) with a high‐fat diet and 20% fructose. Blood samples were collected at baseline and after 60 days for analysis. The findings demonstrated that, in comparison to Group II, the administration of the combination of seed extracts at the dose of 500 mg/kg substantially ( p < 0.05) reduced body weight, liver weight, serum cholesterol, TG, LDL, SGOT, SGPT, ALP, and blood glucose. In contrast, HDL, SOD, and CAT levels increased. The results from GC–MS data reveal the occurrence of hexadecanoic acid methyl ester (methyl palmitate) as well as 9,12‐octadecadienoic acid (linoleic acid) in abundance. The presence of these compounds might be responsible for hepatoprotective, antihyperlipidemic, and antioxidant activities.


  • Open Access

    Dose-Dependent Effects of Sacubitril/Valsartan on Functional Class and Echocardiographic Parameters in Heart Failure with Reduced Ejection Fraction: A Six-Week Follow-Up Study

    by Abeer Sarfaraz, Kaleem Ullah Shaikh, Sana Sarfaraz, Amna Janjua, Atya Zahra, Tooba Osama

    Objectives: This study aimed to compare the dose-dependent effects of sacubitril/valsartan on functional class and echocardiographic parameters over a six-week period. Methodology: This prospective, longitudinal study was conducted between January and February 2024 in the cardiology department of a tertiary care hospital. The study included heart failure patients with reduced ejection fraction who were admitted, treated, and followed up in the cardiac outpatient department six weeks after discharge. Data were collected using the KCCQ questionnaire (approved by the FDA), and echocardiographic measurements of ejection fraction were obtained using the modified Simpson’s method. SPSS version 26 was used for data analysis. Results: A total of 135 patients were included in the study, of which 47 were male. The mean age of the participants was 59.42 ± 11.26 years. Of the patients, 75.6% were hypertensive, and 51.1% were diabetic. The mean ejection fraction before treatment was 31.88 ± 5.91, which increased to 36.18 ± 6.02 post-treatment. The mean KCCQ score prior to treatment was 34.96 ± 6.92, improving to 47.10 ± 6.63 after six weeks. Statistically significant improvements were observed in both the KCCQ score and ejection fraction after six weeks, although the differences between doses of sacubitril/valsartan were not statistically significant. Conclusion: Sacubitril/valsartan, regardless of dose, provides comparable short-term benefits in improving functional class and echocardiographic parameters. These findings suggest that lower doses may be as effective as higher doses in the short term for patients with heart failure and reduced ejection fraction.

  • Open Access

    VISUAL OUTCOMES WITH INTRAOCULAR TRIFOCAL LENS IMPLANT

    by Sana Ahmed Sarfaraz, Muhammad Ali Haider, Hussain Ahmed Khaqan, Nida Usman, Arslan Ahmed, Uzma Sattar, Hasnain Muhammad Buksh, Rahila Ikram

    Background: Cataract surgery has become one of the most common surgeries in the world with one in every four surgeries performed being a cataract extraction and the numbers are expected to increase by 16 percent in the USA alone by 2024 as compared to the current statistics. The aim of the study is to analyze the visual outcomes of intraocular lens implants for various visual ranges. Methods: This non-comparative interventional study was conducted at the Ophthalmology department of Al Ehsan Eye Hospital from Jan to Dec 2021. It included patients who underwent uneventful phacoemulsification with an intraocular lens implant and analysis of the visual outcomes for uncorrected distance (UDVA), uncorrected intermediate distance (UIVA), and uncorrected near distance (UNVA). Results: Independent sample t-test was applied to observe the mean values of recorded far vision on the 1stday, 1 week, and 1 month after the trifocal intraocular lens implantation. It showed a significant difference with a p-value of 0.00 on 1st day, 1 week, and 1 month after was 0.3±0.1, 0.17±0.09, and 0.14±0.08 respectively. Mean improvement in near vision after 1 month was N6 with S.D 1.03 and in intermediate vision was N8±1.4 respectively. Conclusion: Trifocal Intraocular lens implantation offers an improved vision for near, intermediate, and distant visual ranges without the need for correction.


  • Open Access

    Screening of different doses of lyophilized beetroot for their hematopoietic potential.

    by Sana Sarfaraz, Rahela Ikram, Rabia Munawwar, Sabiha Gul

    Background: Beetroots are considered a vital source of nutrition and are usually incorporated into the daily diet to prevent different disease conditions. The therapeutic effect observed is due to the presence of active ingredients in the vegetables. The majority of our population, especially females, suffers from anemia due to malnutrition. The perseverance of this research was to explore the hematopoietic effects of lyophilized beetroot powder at different doses so they could be recommended as a nutritional supplement. Methodology: Albino rabbits weighing 1500-2000 gm of either gender were selected for the study and alienated into three sets. Set I was administered distilled water, whereas sets II and III were given lyophilized beetroot 500 mg/kg and 1000 mg/kg, correspondingly. For hematopoietic evaluation of blood, automated huma count plus was utilized. After adjusting according to their weights, lyophilized beetroot powder was suspended in distilled water and given at 500 mg/kg and 1000 mg/kg to rabbits. They were dosed once daily for two months. Results: The effects were verified before the dosing was scheduled and on the 30th day and 60th day of dosing. The outcomes presented a highly noteworthy increase (pConclusion: From the above, it can be concluded that beetroot possesses pronounced hematopoietic effects and might be beneficial as a non-pharmacological treatment for anemia and thrombocytopenia.

  • A nanoemulsion based transdermal delivery of insulin: Formulation development, optimization, in-vitro permeation across Strat-M® membrane and its pharmacokinetic/pharmacodynamic evaluation

    by Fatima Ramzan Ali, Muhammad Harris Shoaib, Syed Abid Ali, Rabia Ismail Yousuf, Fahad Siddiqui, Rameez Raja, Hafiza Sumaiyya Jamal, Muhammad Talha Saleem, Kamran Ahmed, Muhammad Suleman Imtiaz, et al.


  • Dose dependent anticonvulsant activity of Morus nigra in strychnine induced seizures model

    by Tabbassum Zehra, Sana Sarfaraz, Rahela Ikram

    Herbal medicines have gained tremendous surge of interest in recent years. M. nigra leaves are a rich source of phenolics which are well-known for their antioxidant property. Morus nigra popularly known as black mulberry is considered to be the most significant species of genus Morus. This study was designed to evaluate its activity on seizure model in different doses. .Five groups were made comprising of n=10 animals in each group respectively. Group I was on distilled water, Group II was administered with reference drug diazepam and Group III, IV and V were on 125mg/kg, 250mg/kg and 500mg/kg dose of Morus nigra for 15 days prior to experiment. On day 16th all animals were administered with strychnine after 30 minutes of respective treatments and three parameters were recorded i.e. duration, frequency and onset of seizures. M. nigra treatment showed significant seizure protection as noted by delayed latency of seizures (P<0.05), decrease in frequency and jerk's duration (P<0.05) in comparison to control and reference standard. Most significant (P<0.05) anticonvulsant effects were observed with 500mg/kg dose. Anticonvulsant activity of M. nigra could be due to potentiation of both Gabaergic and glycinergic activities. Antiepileptic potential of extract could also be amplified due to its antioxidant activity. This could serve as a non-pharmacological treatment for seizure management.


  • The incidence and awareness of Rhegmatogenous retinal detachment in Pakistani population

    by Abdul Munim, Sohaib Abbas, Arslan Ahmed, Sana Sarfaraz, Rahila Ikram

    Retinal detachment (RD) describes the separation of neurosensory retina from the underlying pigment epithelium. There are various methods of treating RD but in many cases, an unusual delay between occurrence of retinal detachment and surgery has been observed. This study was conducted to find the extent of factors involved in delay in surgery. This cross sectional study was carried out at LRBT Eye Hospital, Lahore for 6 months. The non-probability, consecutive sampling technique was used. The demographic information was recorded. The patients were asked for causes of delay in retinal detachment surgery and all factors were measured. Data was analyzed by SPSS version 21. The mean age of patients was 52 +/- 9.86 years; the male to female ratio was 1.5:1. About 9.3% patients said that they do not know where to go, 30% patients thought that it was not a severe condition,36.4% patients thought that it would selfheal,17.1% patients didn't go to the doctor due to financial constraints whereas 7.1% patients did not have VR ophthalmologist near their residence. Statistically significant difference was found between the factors and education level of the patients i.e. p-value<0.05. Our study results concluded that people needed to be educated regarding the importance of retinal detachment and surgical procedures and complications associated with it.


  • Rising trend of Nutraceuticals: Evaluation of lyophilized beetroot powder at different doses for its hypolipidemic effects

    by Sana Sarfaraz, Rahela Ikram, Rabia Munawwar, Muhammad Osama, Sabiha Gul, Muhammad Sufian

    A diet comprising of nutrients that would control hypertension as well as hyperlipidemia would be very beneficial over all. This study aimed to assess the effect of lyophilized beet root powder at different doses on lipid profile and hyperlipidemia model. Albino rabbits weighing 1500-2000gms were taken for both studies. Beetroot powder was administered to animals at 500mg/kg and 1000mg/kg doses and after two month dosing the blood samples were withdrawn and lipid profile was assessed. Next a model of hyperlipidemia was created comprising of albino rabbits that were divided into five groups each containing n=6. Group I was considered as control, Group II was marked as Negative control, Group III was taken as standard, whereas Group IV and V were considered as treated and given different doses of beetroot. Blood samples were drawn at baseline, 45th day and at day 60th of study. Highly significant decrease in lipid profile (Cholesterol, LDL and TGS) and significant increase in HDL was observed by both doses after one month. HDL was increased more at 1000mg/kg dose. The presence of flavonoids and saponins in beetroot is responsible for hypolipidemic effect. From our research we came to the conclusion that beetroot powder reduced the lipid profile and could be beneficial in treatment of cardiovascular disease due to atherosclerosis and obesity